Aesop Technology

Aesop Technology is an artificial intelligence (AI) company focused on developing solutions to improve patient safety and enhance the quality of medical coding in healthcare. The company has created two primary products: RxPrime and DxPrime. RxPrime is a medication decision support tool that analyzes inpatient data using patterns from prescriptions and flags potentially inappropriate prescriptions that do not match a patient's diagnosis. It can detect errors such as wrong-drug errors, look-alike-sound-alike (LASA) medication errors, and provide optimal recommendations based on the patient's age, gender, and diagnoses.

DxPrime, on the other hand, is a clinical documentation improvement (CDI) tool that assists physicians in inputting correct diagnoses into electronic health record (EHR) systems. It harnesses AI to analyze medical records and provide suggestions for missing or incorrectly coded diagnoses or procedures. DxPrime is designed to address the challenge of accurately coding from the vast number of diagnosis codes (68,000 under ICD-10-CM) and procedural codes (87,000 under ICD-10-PCS), which were initially designed for billing purposes rather than clinical decision-making.

By assisting physicians in entering proper diagnoses, hospitals using DxPrime have reported a 5-10% increase in revenue per inpatient and fewer denials from insurance companies as of June 2022. Aesop Technology claims that DxPrime has achieved 100% user adoption due to its physician-centric design and clinically relevant solutions.

Aesop Technology was originally a spin-off from Taipei Medical University (TMU) in Taiwan, founded by Professor Yu Chuan (Jack) Li, the current president of the International Medical Informatics Association. In 2020, the company officially established its presence in the US and moved its headquarters to San Francisco. In August 2022, Aesop Technology raised USD 2.95 million in a pre-Series A funding round led by Taiwania Capital, with participation from Colopl Next, 500 Startups, and BE Capital.